BioBonds


For creating a new market for low-interest loans to advance more treatments and cures into clinical trials.

About BioBonds

The Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act – HR 7539 – was introduced in the 118th Congress to advance much-needed treatments and cures for a broad range of diseases and conditions into clinical trials without significantly impacting the taxpayer burden.

HR 7539, the LOANS for Biomedical Research Act, Can Boost Development of Treatments and Cures for All Americans

How HR 7539 Loans and BioBonds Work

United States Capitol Building

Loans for Biomedical Research Act

Legislation provides innovative financing for advancement of promising biomedical therapies into clinical trials.

Read the bill

“BioBonds: Generating Billions in Private-Sector Investment Speeding Treatment and Cure” White Paper

Authored by Karen Petrou, Member, Foundation Fighting Blindness Board of Directors 


Read the White Paper

Organizations Supporting BioBonds

Sign Up to Support the Bill

Alliance for Aging Research logo
BioCytics Inc. Human Applications Lab
Carolina BioOncology Institute
Foundation Fighting Blindness beacon logo
JDRF logo. Improving Lives. Curing Type 1 Diabetes.
National Alliance for Eye and Vision Research logo
Tuberous Sclerosis Alliance Logo
Wilmer Eye Institute. Johns Hopkins Medicine.

American Academy of Optometry
Blind Veterans Association
Choroideremia Research Foundation
The Headache & Migraine Policy Forum
Lupus and Allied Diseases logo
Noah's Hope. Hope for Bridget
Usher Synderome Coalition logo
The Association for Research in Vision and Ophthalmology
BrightFocus Foundation with the tagline Cure in Mind. Cure in Sight.
Cure L B S L
Hope in Focus
Melanoma Research Alliance
RYR 1 Foundation logo
VHL Alliance logo

In the News

Read More
Send Us a Message
Contact Your Congressperson
Draft a Letter